BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25735953)

  • 1. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
    Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
    Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis.
    Kataoka TR; Ueshima C; Hirata M; Minamiguchi S; Haga H
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
    Zheng G; Jia L; Yang AG
    Front Immunol; 2022; 13():791975. PubMed ID: 35185887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.
    Takei Y; Ueshima C; Kataoka TR; Hirata M; Sugimoto A; Rokutan-Kurata M; Moriyoshi K; Ono K; Murakami I; Iwamoto S; Haga H
    Oncotarget; 2017 Jun; 8(23):36964-36972. PubMed ID: 28445138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.
    Wiśniewski A; Kowal A; Wyrodek E; Nowak I; Majorczyk E; Wagner M; Pawlak-Adamska E; Jankowska R; Ślesak B; Frydecka I; Kuśnierczyk P
    Tissue Antigens; 2015 Jun; 85(6):466-75. PubMed ID: 25855135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Involvement of Human Mast Cells in the Establishment of Pregnancy via Killer Cell Ig-Like Receptor 2DL4.
    Ueshima C; Kataoka TR; Hirata M; Sugimoto A; Iemura Y; Minamiguchi S; Nomura T; Haga H
    Am J Pathol; 2018 Jun; 188(6):1497-1508. PubMed ID: 29577936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
    Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
    Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
    Yan WH; Fan LA
    Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of KIR2DL4 (CD158d), a putative NK cell receptor for HLA-G, does not influence susceptibility to asthma.
    Le Page ME; Goodridge JP; Zhang G; Holt PG; Sly P; Witt CS
    Tissue Antigens; 2013 Oct; 82(4):276-9. PubMed ID: 24033084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-G, a ligand for the natural killer receptor KIR2DL4, is expressed by eutopic endometrium only in the menstrual phase.
    Kawashima M; Maeda N; Adachi Y; Takeuchi T; Yamamoto Y; Izumiya C; Hayashi K; Furihata M; Udaka K; Fukaya T
    Fertil Steril; 2009 Feb; 91(2):343-9. PubMed ID: 18314122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
    Zhao L; Purandare B; Zhang J; Hantash BM
    Hum Immunol; 2013 Apr; 74(4):417-24. PubMed ID: 23228393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.
    Brusilovsky M; Cordoba M; Rosental B; Hershkovitz O; Andrake MD; Pecherskaya A; Einarson MB; Zhou Y; Braiman A; Campbell KS; Porgador A
    J Immunol; 2013 Nov; 191(10):5256-67. PubMed ID: 24127555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy.
    Yan WH; Lin A; Chen BG; Zhou MY; Dai MZ; Chen XJ; Gan LH; Zhu M; Shi WW; Li BL
    Am J Reprod Immunol; 2007 Apr; 57(4):233-42. PubMed ID: 17362384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.
    Moradi S; Berry R; Pymm P; Hitchen C; Beckham SA; Wilce MC; Walpole NG; Clements CS; Reid HH; Perugini MA; Brooks AG; Rossjohn J; Vivian JP
    J Biol Chem; 2015 Apr; 290(16):10460-71. PubMed ID: 25759384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasion.
    Guo Y; Lee CL; So KH; Gao J; Yeung WS; Yao Y; Lee KF
    PLoS One; 2013; 8(10):e76023. PubMed ID: 24098421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G.
    Yu YR; Tian XH; Wang Y; Feng MF
    Biochemistry (Mosc); 2006; 71 Suppl 1():S60-4, 4-5. PubMed ID: 16487070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to comment on "killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations".
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 May; 192(9):4003-4. PubMed ID: 24748632
    [No Abstract]   [Full Text] [Related]  

  • 20. The Influence of Cytomegalovirus on Expression of HLA-G and its Ligand KIR2DL4 by Human Peripheral Blood Leucocyte Subsets.
    Albayati Z; Alyami A; Alomar S; Middleton D; Bonnett L; Aleem S; Flanagan BF; Christmas SE
    Scand J Immunol; 2017 Nov; 86(5):396-407. PubMed ID: 28817184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.